Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gut

Showing results (171-180 of 18,236) with videos related to

Pageof 1,824
Sort By:
Gut|May 29, 2015
POU2F2-oriented network promotes human gastric cancer metastasisSi-Meng Wang, Jun Tie, Wen-Lan Wang, et al.
Gut|August 12, 2016
Efficacy and safety of sofosbuvir plus simeprevir therapy in Egyptian patients with chronic hepatitis C: a real-world experienceHisham R El-Khayat, Yasser M Fouad, Mohsen Maher, et al.
Gut|August 12, 2016
Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloatingTom Holvoet, Marie Joossens, Jun Wang, et al.
Gut|June 6, 2015
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionDavid Y Zhang, Nicolas Goossens, Jinsheng Guo, et al.
Gut|October 1, 1982
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasisT K Daneshmend, M Homeida, C M Kaye, et al.
Gut|October 1, 1982
Water and electrolyte absorption by the colon in tropical sprueB S Ramakrishna, V I Mathan
Gut|February 17, 2025
Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deteriorationMelinda Y Hardy, Amy K Russell, Lee M Henneken, et al.
Gut|February 18, 2025
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumabYuta Myojin, Sepideh Babaei, Rajiv Trehan, et al.
Gut|January 11, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCUJavier P Gisbert, María G Donday, Sabino Riestra, et al.
Gut|January 27, 2025
Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance: a prospective longitudinal cohort studyTsuyoshi Hamada, Hiroki Oyama, Daniel Nevo, et al.
Pageof 1,824

Showing results (171-180 of 18,236) with videos related to

Sort By:
Pageof 1,824
Gut|May 29, 2015
POU2F2-oriented network promotes human gastric cancer metastasisSi-Meng Wang, Jun Tie, Wen-Lan Wang, et al.
Gut|August 12, 2016
Efficacy and safety of sofosbuvir plus simeprevir therapy in Egyptian patients with chronic hepatitis C: a real-world experienceHisham R El-Khayat, Yasser M Fouad, Mohsen Maher, et al.
Gut|August 12, 2016
Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloatingTom Holvoet, Marie Joossens, Jun Wang, et al.
Gut|June 6, 2015
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionDavid Y Zhang, Nicolas Goossens, Jinsheng Guo, et al.
Gut|October 1, 1982
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasisT K Daneshmend, M Homeida, C M Kaye, et al.
Gut|October 1, 1982
Water and electrolyte absorption by the colon in tropical sprueB S Ramakrishna, V I Mathan
Gut|February 17, 2025
Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deteriorationMelinda Y Hardy, Amy K Russell, Lee M Henneken, et al.
Gut|February 18, 2025
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumabYuta Myojin, Sepideh Babaei, Rajiv Trehan, et al.
Gut|January 11, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCUJavier P Gisbert, María G Donday, Sabino Riestra, et al.
Gut|January 27, 2025
Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance: a prospective longitudinal cohort studyTsuyoshi Hamada, Hiroki Oyama, Daniel Nevo, et al.
Pageof 1,824